Ashwagandha: What the Clinical Trials Actually Say About Stress, Testosterone, and Performance

The "natural testosterone booster" category is a graveyard of hype. Tribulus terrestris, D-aspartic acid, fenugreek, horny goat weed -- the supplement industry has thrown every plant extract it can find at men's insecurity about their hormone levels, and the data behind most of them ranges from nonexistent to actively discouraging. You could fill a dumpster with the failed RCTs on tribulus alone.

Ashwagandha (Withania somnifera) is a different story. Not because it is a miracle herb that will turn you into a hormonal outlier -- it will not. But because it is one of the very few compounds in this category where the clinical trial evidence is actually positive, replicated, and published in real peer-reviewed journals. When we looked through the research for this guide, we found multiple randomized, double-blind, placebo-controlled trials showing measurable effects on cortisol, testosterone, strength output, anxiety, and sleep. That is more than you can say for nearly anything else sitting in the "men's health" section of a supplement store.

The catch, as always, is that the truth is more nuanced than the marketing. So let us walk through exactly what the data says -- study by study, number by number -- and build a picture of what ashwagandha can realistically do for you, what it cannot do, and how to use it properly if you decide it is worth adding to your stack.

What Ashwagandha Actually Is (and What an Adaptogen Means)

Ashwagandha is a shrub native to India, the Middle East, and parts of Africa. It has been used in Ayurvedic medicine for over 3,000 years, classified as a rasayana -- a rejuvenating tonic. The name translates roughly to "smell of the horse," which refers both to the root's distinct odor and the traditional belief that it confers the strength and vitality of a horse. Traditional use is not evidence, but it does explain why researchers eventually started running controlled trials on it.

The active compounds in ashwagandha are called withanolides -- a group of naturally occurring steroidal lactones. The two most important for pharmacological effects are withaferin A and withanolide D. Different parts of the plant contain different concentrations of these compounds. The root tends to have a more balanced withanolide profile, while the leaves are higher in withaferin A specifically. This distinction matters when we compare standardized extracts later.

Ashwagandha is classified as an adaptogen. That term gets thrown around loosely in wellness circles, but it has a specific pharmacological definition established by Lazarev in 1947 and refined by Brekhman and Dardymov in 1969. To qualify as an adaptogen, a substance must:

• Produce a nonspecific response -- meaning it increases resistance to a broad range of stressors (physical, chemical, biological) rather than targeting a single pathway
• Have a normalizing effect on physiology regardless of the direction of the deviation -- it should help whether you are overactivated or underactivated
• Be nontoxic and produce minimal side effects at therapeutic doses

In practical terms, an adaptogen modulates the stress response rather than simply stimulating or sedating. If your cortisol is running high from chronic stress, an adaptogen should help bring it down. If your stress response is blunted from burnout, it should help restore normal function. This bidirectional quality is what separates adaptogens from simple stimulants or sedatives, and it is the mechanism most relevant to ashwagandha's clinical effects.

How It Works: HPA Axis Modulation and the Stress Response

The primary mechanism through which ashwagandha produces its effects is modulation of the hypothalamic-pituitary-adrenal (HPA) axis. The HPA axis is your body's central stress response system, and understanding it makes the entire research picture click into place.

Here is the cascade in simplified form: your hypothalamus detects a stressor and releases corticotropin-releasing hormone (CRH). CRH signals the pituitary gland to release adrenocorticotropic hormone (ACTH). ACTH travels to the adrenal glands and triggers the release of cortisol. Cortisol then feeds back to the hypothalamus and pituitary to shut the system off once the stressor has passed. This negative feedback loop is supposed to be self-regulating.

The problem is chronic stress. When stressors are constant -- work deadlines, sleep deprivation, financial pressure, overtraining, relationship strain -- the HPA axis stays activated longer and more frequently than it was designed for. The negative feedback loop starts to lose sensitivity. Cortisol levels remain elevated. And elevated cortisol over sustained periods does real damage to the things lifters care about: it promotes muscle protein breakdown (catabolic), increases abdominal fat storage, impairs recovery, disrupts sleep architecture, suppresses testosterone production, and increases anxiety.

Ashwagandha's withanolides appear to work at multiple points along this axis. Preclinical data suggests they modulate GABA receptor signaling (the primary inhibitory neurotransmitter system), reduce the sensitivity of CRH release, and support the cortisol negative feedback loop so it functions more effectively. The net result is a dampening of the exaggerated stress response without sedation or blunting of normal stress reactivity. You still respond to acute stressors -- you just recover from them faster and do not stay in a chronically elevated state.

This HPA axis modulation is the single mechanism that explains most of ashwagandha's observed effects. Lower chronic cortisol leads to less testosterone suppression, better sleep, reduced anxiety, improved recovery, and over time, better training outcomes. The downstream effects are broad because the upstream mechanism is fundamental.

Cortisol Reduction: The Strongest Evidence

The cortisol reduction data is where ashwagandha's evidence is most convincing, and the landmark study is Chandrasekhar et al. (2012).

This was a prospective, double-blind, randomized, placebo-controlled trial published in the Indian Journal of Psychological Medicine. The study enrolled 64 adults with a history of chronic stress, randomized them to either 300mg of KSM-66 ashwagandha root extract twice daily (600mg total) or placebo, and followed them for 60 days. The primary outcome was serum cortisol levels. The secondary outcomes included scores on standardized stress assessment scales (the Perceived Stress Scale, the General Health Questionnaire, and the Depression Anxiety Stress Scales).

The results were striking. The ashwagandha group showed a 27.9% reduction in serum cortisol compared to a 7.9% reduction in the placebo group. That is a net difference of roughly 20 percentage points, which is large for a botanical intervention. The stress assessment scores improved substantially across all three scales, with the ashwagandha group showing 44% improvement on the PSS compared to 5.5% in the placebo group.

This study has been cited extensively and is the foundation of most cortisol-related marketing claims for ashwagandha. To be fair about its limitations: the sample size was moderate (64 subjects), the population was specifically selected for chronic stress (which means the effect may be smaller in people who are not chronically stressed), and it was conducted using a specific branded extract (KSM-66). But the study design was solid -- double-blind, placebo-controlled, with objective biomarker measurement -- and the effect size was large enough that it has been supported by subsequent research.

Auddy et al. (2008) found similar cortisol reductions using Sensoril (a different standardized ashwagandha extract using root and leaf), with a 24.2% reduction in cortisol at a dose of 250mg per day. Salve et al. (2019) replicated the stress and cortisol findings with KSM-66 at both 250mg and 600mg daily doses, with the higher dose producing greater cortisol reduction.

Testosterone: Real Data, Realistic Expectations

This is the section most guys skip straight to, so let us be direct: ashwagandha does appear to increase testosterone, and the evidence is legitimate. But the magnitude is modest, and the context matters.

Wankhede et al. (2015)

Published in the Journal of the International Society of Sports Nutrition, this is the most frequently cited study for ashwagandha's effects on testosterone in a resistance-trained population. It was an 8-week, randomized, double-blind, placebo-controlled trial in 57 young men (18-50 years old) with little resistance training experience. Subjects received either 300mg of KSM-66 twice daily (600mg total) or placebo, and both groups followed the same resistance training program.

The testosterone results: the ashwagandha group showed a significant increase in testosterone compared to placebo. The specific numbers from the study showed testosterone increasing from a baseline mean of 630 ng/dL to 726 ng/dL in the ashwagandha group, representing a roughly 15% increase. The placebo group saw a smaller increase attributable to the resistance training itself.

Lopresti et al. (2019)

This 16-week, randomized, double-blind, placebo-controlled trial published in The Aging Male studied 57 overweight men aged 40-70. Subjects received 300mg of KSM-66 ashwagandha extract once daily or placebo. The ashwagandha group showed a 14.7% increase in testosterone and a 18% increase in DHEA-S (a precursor hormone) compared to placebo. Notably, this study used a lower dose (300mg once daily vs. 600mg in Wankhede) and an older, overweight population -- suggesting the testosterone effects are not limited to young trainees.

Putting the Numbers in Context

A 15% increase in testosterone sounds good in isolation. But let us ground it in reality. If a man has a total testosterone level of 450 ng/dL (which is on the lower end of the reference range but not clinically hypogonadal), a 15% increase would bring him to approximately 518 ng/dL. That is a meaningful bump -- it moves him from the bottom quartile to a more comfortable mid-range. He might notice subtle improvements in energy, recovery, and libido.

But compare that to exogenous testosterone replacement therapy, which can increase levels from 300 ng/dL to 800+ ng/dL, or to supraphysiological steroid use, which can push levels to 2,000-5,000+ ng/dL. Ashwagandha is operating in an entirely different universe of effect size.

The mechanism behind the testosterone increase is likely indirect. Ashwagandha does not directly stimulate Leydig cells (the cells in the testes that produce testosterone) the way something like hCG does. Instead, the leading hypothesis is that reducing chronic cortisol removes a suppressive influence on testosterone production. Cortisol and testosterone have a well-documented inverse relationship -- when cortisol stays elevated, the hypothalamic-pituitary-gonadal axis is downregulated. By normalizing cortisol, ashwagandha allows the HPG axis to function closer to its potential.

This is why the testosterone effect is most pronounced in stressed, underslept, or overweight populations -- these are the groups most likely to have cortisol-mediated testosterone suppression. If you are already lean, well-rested, and managing stress effectively, the testosterone increase from ashwagandha is likely to be smaller.

Strength and Performance: The Gym-Relevant Numbers

The Wankhede 2015 study did not just measure testosterone -- it measured strength and body composition outcomes as well, and this is where the data gets interesting for lifters.

Over the 8-week training period, the ashwagandha group showed significantly greater improvements compared to placebo in:

• Bench press 1RM: The ashwagandha group increased bench press by an average of 44 lbs (20 kg) compared to 26.4 lbs (12 kg) in the placebo group
• Leg extension strength: Significantly greater gains in the ashwagandha group
• Muscle size: Greater increases in arm and chest circumference measurements in the ashwagandha group
• Body fat reduction: The ashwagandha group showed a significantly greater decrease in body fat percentage (3.47% reduction vs. 1.46% in placebo)
• Muscle recovery: Serum creatine kinase levels (a marker of muscle damage) were lower in the ashwagandha group after exercise, suggesting improved recovery

These are substantial differences, especially for an 8-week period. The bench press difference is particularly noteworthy -- an additional 18 lbs of progress over two months is meaningful by any standard.

Ziegenfuss et al. (2018) added to this with a study on Sensoril ashwagandha and exercise performance. In a randomized, double-blind, placebo-controlled trial with 40 healthy recreational athletes, Sensoril supplementation (500mg daily) for 12 weeks produced significant improvements in VO2 max, time to exhaustion on a treadmill test, and upper and lower body strength compared to placebo.

Sandhu et al. (2010) looked at power output specifically and found improvements in velocity and power in both bench press and back squat movements during resistance training protocols with ashwagandha supplementation.

The performance picture is not solely driven by testosterone changes. Ashwagandha's effects on recovery (via cortisol reduction and reduced exercise-induced muscle damage), sleep quality (more on this below), and potentially neuromuscular function all contribute. If you recover better between sessions, sleep more deeply, and have a less catabolic hormonal environment, you are going to make better progress in the gym. The performance improvements are likely a compound effect of multiple mechanisms rather than a single pathway.

Anxiety and Stress Reduction

Ashwagandha's anxiolytic (anti-anxiety) effects have the broadest and most replicated evidence base of any of its claimed benefits. Multiple independent research groups have found significant effects across different populations and study designs.

Pratte et al. (2014) published a systematic review in the Journal of Alternative and Complementary Medicine examining five human RCTs on ashwagandha for anxiety. All five studies showed significant improvement in anxiety outcomes compared to placebo, with effect sizes ranging from moderate to large. The review concluded that ashwagandha "may hold promise as a relatively safe and effective intervention for stress and anxiety."

The specific studies worth highlighting:

• Chandrasekhar 2012 (the cortisol study discussed above): Beyond cortisol, this study showed a 44% improvement on the Perceived Stress Scale and significant improvements on the Depression Anxiety Stress Scales in the ashwagandha group. These are validated psychometric instruments, not vague self-reports.
• Cooley et al. (2009): A naturalistic study comparing ashwagandha (300mg twice daily) to psychotherapy and placebo. The ashwagandha group showed significant improvements in anxiety, concentration, fatigue, social functioning, vitality, and overall quality of life. The anxiety score improvement was 56.5% in the ashwagandha group vs. 30.5% in placebo.
• Lopresti et al. (2019b): A 60-day RCT using 240mg of Shoden ashwagandha extract (standardized to 35% withanolides) showed significant reductions in morning cortisol and improvements in self-reported stress and sleep quality compared to placebo.

The consistency across studies is unusual for a botanical supplement. Most herbal interventions have one or two positive studies surrounded by a sea of null or mixed results. Ashwagandha's anxiety data is genuinely consistent -- positive results from multiple research groups, multiple extracts, multiple countries, and multiple assessment tools.

For lifters specifically, this matters because chronic psychological stress is one of the most underappreciated obstacles to training progress. Elevated stress disrupts sleep, increases catabolic hormones, impairs appetite regulation, and reduces motivation and adherence. If ashwagandha can meaningfully reduce your background stress levels, the downstream training benefits follow naturally. You are not just supplementing for a feeling -- you are supplementing for a physiological environment that supports adaptation.

Sleep Quality: The Langade 2019 Data

Langade et al. (2019) published a study in Cureus that directly examined ashwagandha's effects on sleep. This was a double-blind, randomized, placebo-controlled study of 80 healthy subjects divided into two groups: those with insomnia and those without. Subjects received either 300mg of KSM-66 ashwagandha root extract twice daily (600mg total) or placebo for 8 weeks.

The results on sleep parameters:

• Sleep onset latency (time to fall asleep) improved significantly in the ashwagandha group -- both in insomnia and non-insomnia subjects
• Total sleep time increased in the ashwagandha group
• Sleep quality (measured by the Pittsburgh Sleep Quality Index, a validated clinical tool) improved significantly
• Sleep efficiency (percentage of time in bed actually spent sleeping) improved
• The effects were more pronounced in the insomnia subgroup but still present in the healthy sleepers

Langade et al. (2021) followed up with a second study of 150 subjects and confirmed the findings, reporting that ashwagandha improved overall sleep quality, sleep onset latency, and mental alertness upon waking. This follow-up used a larger sample and further strengthened the evidence.

The sleep mechanism ties back to both the HPA axis modulation (lower cortisol at night means less hyperarousal) and GABAergic activity. Ashwagandha's withanolides have been shown to potentiate GABA receptor signaling in preclinical models, and GABA is the primary neurotransmitter involved in sleep initiation. This dual mechanism -- hormonal plus neurotransmitter -- likely explains why the sleep effects are relatively robust.

For anyone in the lifting community, the connection to recovery is direct. Sleep is where the majority of growth hormone release occurs, where protein synthesis rates peak, and where the nervous system recovers from training stress. If ashwagandha can meaningfully improve sleep quality, even moderately, the compounding effect on training adaptation over weeks and months is real.

KSM-66 vs. Sensoril vs. Generic Ashwagandha Root Powder

Not all ashwagandha products are the same. The extract you choose determines the withanolide concentration, the research backing, and the effective dose. This comparison matters more than most people realize.

KSM-66: The Most-Studied Extract

KSM-66 is produced by Ixoreal Biomed and uses a root-only extraction process. It holds the largest body of published clinical research of any ashwagandha extract, with studies covering testosterone, cortisol, stress, sleep, endurance, cognitive function, and sexual health. The testosterone data (Wankhede 2015, Lopresti 2019) and the sleep data (Langade 2019) were both conducted with KSM-66 specifically. If testosterone and strength are your primary goals, KSM-66 has the most directly relevant data.

Sensoril: Higher Concentration, Lower Dose

Sensoril is produced by Natreon Inc. and uses both root and leaf, resulting in a higher withanolide concentration (at least 10% compared to KSM-66's 5%). This means effective doses are lower -- 125-250mg of Sensoril delivers a comparable or greater amount of withanolides to 300-600mg of KSM-66. The Sensoril research is particularly strong for cortisol and anxiety (Auddy 2008), and Ziegenfuss 2018 demonstrated its efficacy for exercise performance. Some people prefer Sensoril because the lower pill volume is more convenient.

The inclusion of leaf extract in Sensoril means higher withaferin A content. Withaferin A has shown anti-inflammatory and potentially anti-tumor properties in preclinical research, but it is also the compound most associated with liver stress at very high doses in case reports. At the doses used in clinical trials (125-250mg), this has not been a documented issue.

Generic Root Powder: Buyer Beware

Generic ashwagandha root powder -- the kind you find in bulk bins or cheap capsules without a branded extract name -- is the wild west. The withanolide content is unstandardized and can vary from batch to batch by an order of magnitude. You might get a product with 3% withanolides or one with 0.5%. Without standardization, you cannot reliably dose it, and you have no clinical data specific to that product to reference.

The price per gram is obviously lower, but the price per effective dose of withanolides is often comparable or even higher than a standardized extract. You also need to take far more of it -- 3-6 grams of raw root powder vs. 300-600mg of KSM-66 -- which means more capsules and more gastrointestinal load.

Our recommendation: use a standardized extract. KSM-66 and Sensoril both have the research, quality control, and standardization to give you consistent results. The cost difference between a branded extract and generic powder is $5-10 per month. That is not a meaningful savings when the generic product gives you no confidence in what you are actually getting.

Dosing Protocols

Dosing depends on which extract you are using. The clinical trial data gives us clear guidance:

KSM-66

• Standard dose: 300mg twice daily (600mg total) -- this is the dose used in the Chandrasekhar cortisol study, the Wankhede strength study, and the Langade sleep study
• Lower dose option: 300mg once daily -- Lopresti 2019 showed testosterone increases at this dose, and Salve 2019 found cortisol and stress reduction at 250mg daily
• Duration: Minimum 8 weeks based on study timelines. Most trials ran 8-16 weeks.

Sensoril

• Standard dose: 125-250mg once daily -- the Auddy 2008 stress study used 125mg and 250mg doses with good results at both
• Higher dose for performance: 500mg daily was used in the Ziegenfuss 2018 exercise study
• Duration: 8-12 weeks minimum

General Guidelines

• Timing: Take with food to improve absorption and reduce any chance of GI discomfort. If using for sleep, take the evening dose 30-60 minutes before bed. If using primarily for stress and cortisol, morning and evening split dosing matches most study protocols.
• Cycling: Most clinical trials lasted 8-12 weeks. There is limited safety data beyond 12 weeks of continuous use. A common recommendation is 8-12 weeks on, followed by 2-4 weeks off, though this is based on precautionary principle rather than evidence of harm from continuous use.
• Standardization: Regardless of which extract you choose, verify the label states the withanolide percentage. For KSM-66, look for "standardized to ≥5% withanolides." For Sensoril, "standardized to ≥10% withanolides." If the label does not specify, you do not know what you are getting.

Side Effects and Safety

Ashwagandha has a generally good safety profile in the clinical trial literature. Across the studies reviewed for this guide, adverse events were rare and typically mild. But "generally well-tolerated" is not the same as "risk-free," and there are several things you need to know.

Common Side Effects (Mild, Dose-Dependent)

• Gastrointestinal discomfort: Nausea, stomach upset, and diarrhea are the most commonly reported side effects, especially at higher doses or on an empty stomach. Taking ashwagandha with food usually resolves this.
• Drowsiness: Some people experience mild sedation, especially when starting. This is why evening dosing often works better. If it makes you drowsy, avoid taking it before training or driving.
• Headache: Reported occasionally in clinical trials, typically in the first week of use and resolving with continued supplementation.

Less Common but More Serious Concerns

• Thyroid hormone interaction: Multiple studies have shown that ashwagandha can increase thyroid hormone levels. Sharma et al. (2018) found significant increases in T4 and T3 in subclinically hypothyroid patients over 8 weeks. While this is potentially therapeutic for people with sluggish thyroids, it is dangerous for anyone with hyperthyroidism or Graves' disease, and it can alter the required dose of thyroid medication for people on levothyroxine or similar drugs.
• Liver concerns: There have been rare case reports of liver injury (hepatotoxicity) associated with ashwagandha use, including several documented in post-market surveillance databases like the Drug-Induced Liver Injury Network. A review by Bjornsson et al. (2020) identified ashwagandha as an emerging cause of liver injury. The cases are rare relative to the millions of people taking ashwagandha, but they exist. This is one reason cycling (taking breaks) is a prudent approach.
• Immunomodulatory effects: Ashwagandha has been shown to modulate immune function, including increasing natural killer cell activity and immunoglobulin production. For most healthy people, this is neutral or positive. For people with autoimmune conditions (rheumatoid arthritis, lupus, multiple sclerosis, Hashimoto's thyroiditis), stimulating an already overactive immune system is potentially harmful.

Who Should and Should Not Take Ashwagandha

Good Candidates

• Chronically stressed individuals who are experiencing elevated cortisol, poor sleep, and the downstream effects on recovery and body composition. This is the population where the evidence is strongest.
• Lifters looking to optimize their hormonal environment within natural ranges, especially those in the lower-normal range of testosterone who are not candidates for TRT.
• People with poor sleep quality who want a non-pharmaceutical intervention. Ashwagandha combined with magnesium covers complementary sleep mechanisms.
• Anyone dealing with significant anxiety that affects daily functioning and training adherence. The anxiolytic data is among the most consistent in the ashwagandha literature.
• Recreational and competitive athletes looking for legal, evidence-based ergogenic support. Ashwagandha is not on any banned substance list (WADA, NCAA, etc.) as of the time of writing.

Who Should Avoid It

• People with hyperthyroidism or Graves' disease. Ashwagandha can increase thyroid hormone levels, which is the opposite of what these conditions need. This is a hard contraindication -- do not take it.
• People on thyroid medication. If you are taking levothyroxine, liothyronine, or any thyroid hormone replacement, ashwagandha can alter your required dose. Do not add it without discussing it with your endocrinologist first.
• People with autoimmune conditions. The immune-stimulating properties of ashwagandha can theoretically worsen autoimmune diseases. This includes Hashimoto's thyroiditis (even though Hashimoto's involves the thyroid, it is an autoimmune condition), rheumatoid arthritis, lupus, and multiple sclerosis. Talk to your rheumatologist or immunologist before using it.
• Pregnant or breastfeeding women. There is insufficient safety data for use during pregnancy, and some traditional sources classify ashwagandha as an abortifacient (capable of inducing miscarriage) at high doses. Do not use it during pregnancy.
• People taking immunosuppressant drugs. If you are on medications that suppress immune function (post-transplant drugs, certain cancer therapies), ashwagandha's immunomodulatory effects could interfere with treatment.
• People taking sedatives or anti-anxiety medications. Ashwagandha has GABAergic activity that could potentially amplify the effects of benzodiazepines, barbiturates, or other CNS depressants. If you are on prescription anxiolytics, consult your prescriber before adding ashwagandha.
• People scheduled for surgery. Ashwagandha may affect blood pressure and blood sugar levels, and could interact with anesthesia. Discontinue use at least 2 weeks before scheduled surgery.

The Bottom Line

Ashwagandha occupies a rare position in the supplement landscape: a botanical with traditional use that actually holds up under modern clinical scrutiny. Not perfectly, not without caveats, but with a consistency and effect size that is genuinely unusual for this category.

Here is what the evidence supports:

• Cortisol reduction: The strongest and most replicated finding. Expect a 20-30% reduction in serum cortisol if you are chronically stressed. Multiple RCTs confirm this.
• Testosterone: Real but modest. Roughly 15% increases in the best studies, likely mediated by cortisol reduction rather than direct gonadal stimulation. Most meaningful for men in the lower-normal range.
• Strength and body composition: The Wankhede data showed meaningful improvements in bench press, leg extension strength, muscle size, and body fat percentage. The mechanisms are likely multifactorial -- hormonal, recovery-related, and potentially neuromuscular.
• Anxiety and stress: The most consistently replicated benefit across independent research groups. Large effect sizes across multiple validated assessment tools.
• Sleep: Improved sleep onset latency, total sleep time, and sleep quality in both people with insomnia and healthy sleepers. Complementary to magnesium and other non-pharmaceutical sleep interventions.

Here is what it will not do:

• Replace TRT for genuinely hypogonadal men
• Produce visible physique changes on its own without proper training and nutrition
• Overcome the effects of severe sleep deprivation, overtraining, or a terrible diet
• Work as a standalone treatment for clinical anxiety disorders or major depression

Our practical recommendations:

• Use a standardized extract. KSM-66 (300-600mg daily) or Sensoril (125-250mg daily). Do not waste money on unstandardized root powder.
• Take it with food. Improves absorption and reduces GI side effects.
• Give it time. 8-12 weeks minimum. The clinical trial evidence is based on sustained use, not acute effects.
• Cycle it. 8-12 weeks on, 2-4 weeks off, as a precaution given the limited long-term continuous-use data.
• Stack it smartly. Ashwagandha pairs well with creatine (different mechanisms, no interaction), magnesium (complementary sleep and recovery benefits), vitamin D3 (another common deficiency that affects testosterone), and zinc (cofactor in testosterone synthesis).
• Check your thyroid. Get a baseline TSH if you have not recently, and monitor for any hyperthyroid symptoms during use.
• Keep expectations grounded. Ashwagandha is a legitimate evidence-based supplement. It is not a magic pill. The best results come when it is part of a comprehensive approach that includes proper training, sufficient protein, adequate sleep, and reasonable stress management. It optimizes the environment. It does not override bad inputs.

In the hierarchy of evidence-based supplements for lifters, ashwagandha sits in a strong second tier -- behind creatine (which has an absurdly deep evidence base) and alongside vitamin D, magnesium, and fish oil. It is one of the very few things in the "natural test booster" category that we can recommend without asterisks or qualifications. The data is there. The effects are real. Just use it with your eyes open about what those effects actually are, and you will not be disappointed.

References

1. Chandrasekhar, K., Kapoor, J., & Anishetty, S. (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine, 34(3), 255-262.
2. Wankhede, S., Langade, D., Joshi, K., Sinha, S.R., & Bhattacharyya, S. (2015). Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial. Journal of the International Society of Sports Nutrition, 12, 43.
3. Lopresti, A.L., Drummond, P.D., & Smith, S.J. (2019). A randomized, double-blind, placebo-controlled, crossover study examining the hormonal and vitality effects of ashwagandha (Withania somnifera) in aging, overweight males. The Aging Male, 22(1), 43-50.
4. Langade, D., Kanchi, S., Salve, J., Debnath, K., & Ambegaokar, D. (2019). Efficacy and safety of ashwagandha (Withania somnifera) root extract in insomnia and anxiety: a double-blind, randomized, placebo-controlled study. Cureus, 11(9), e5797.
5. Langade, D., Thakare, V., Kanchi, S., & Kelgane, S. (2021). Clinical evaluation of the pharmacological impact of ashwagandha root extract on sleep in healthy volunteers and insomnia patients: a double-blind, randomized, parallel-group, placebo-controlled study. Journal of Ethnopharmacology, 264, 113276.
6. Auddy, B., Hazra, J., Mitra, A., Abedon, B., & Ghosal, S. (2008). A standardized Withania somnifera extract significantly reduces stress-related parameters in chronically stressed humans: a double-blind, randomized, placebo-controlled study. JANA, 11(1), 50-56.
7. Salve, J., Pate, S., Debnath, K., & Langade, D. (2019). Adaptogenic and anxiolytic effects of ashwagandha root extract in healthy adults: a double-blind, randomized, placebo-controlled clinical study. Cureus, 11(12), e6466.
8. Pratte, M.A., Nanavati, K.B., Young, V., & Morley, C.P. (2014). An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera). Journal of Alternative and Complementary Medicine, 20(12), 901-908.
9. Cooley, K., Szczurko, O., Perri, D., Mills, E.J., Bernhardt, B., Zhou, Q., & Seely, D. (2009). Naturopathic care for anxiety: a randomized controlled trial ISRCTN78958974. PLoS One, 4(8), e6628.
10. Lopresti, A.L., Smith, S.J., Malvi, H., & Kodgule, R. (2019b). An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: a randomized, double-blind, placebo-controlled study. Medicine, 98(37), e17186.
11. Ziegenfuss, T.N., Kedia, A.W., Sandrock, J.E., Raub, B.J., Kerksick, C.M., & Lopez, H.L. (2018). Effects of an aqueous extract of Withania somnifera on strength training adaptations and recovery: the STAR trial. Nutrients, 10(11), 1807.
12. Sandhu, J.S., Shah, B., Shenoy, S., Chauhan, S., Lavekar, G.S., & Padhi, M.M. (2010). Effects of Withania somnifera (Ashwagandha) and Terminalia arjuna (Arjuna) on physical performance and cardiorespiratory endurance in healthy young adults. International Journal of Ayurveda Research, 1(3), 144-149.
13. Sharma, A.K., Basu, I., & Singh, S. (2018). Efficacy and safety of ashwagandha root extract in subclinical hypothyroid patients: a double-blind, randomized placebo-controlled trial. Journal of Alternative and Complementary Medicine, 24(3), 243-248.
14. Bjornsson, H.K., Bjornsson, E.S., Avula, B., et al. (2020). Ashwagandha-induced liver injury: a case series from Iceland and the US Drug-Induced Liver Injury Network. Liver International, 40(4), 825-829.
15. Brekhman, I.I. & Dardymov, I.V. (1969). New substances of plant origin which increase nonspecific resistance. Annual Review of Pharmacology, 9(1), 419-430.